Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
AngioDynamics Inc Completes Acquisition of Navilyst Medical
AngioDynamics Inc announced that it has completed its acquisition of Navilyst Medical. Based on the closing price of $12.44 on May 21, 2012 the transaction is valued at $355 million. The acquisition and related transaction costs were financed through the issuance of approximately 9.5 million shares of AngioDynamics Common Stock, $150 million in drawn acquisition debt financing, and $97 million of balance sheet cash. To satisfy any working capital adjustment and potential indemnification claims that may arise $20 million of purchase consideration has been placed in escrow.
Latest Developments for AngioDynamics Inc
- Angiodynamics Inc Lowers FY 2013 Guidance
- Angiodynamics Inc Issues Q3 2013 Guidance Below Analysts' Estimates
- Angiodynamics Inc Sees FY 2013 Revenue Guidance To A Slightly Lower Midpoint Of Prior Range; Reaffirms FY 2013 EPS Guidance-Conference Call
- Angiodynamics Inc Reaffirms FY 2013 Guidance; Lowers FY 2013 Revenue And EBITDA Guidance
Latest Key Developments in Medical
- Share this
- Link this
- Digg this
Follow Reuters